Vimarsana
Biggest News Aggregation in the World

Page 7 - Recode Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recode Therapeutics Today - Breaking & Trending Today

UT Southwestern Ranked No. 1 in Texas, Fourth in Nation for Tech Transfer - Vimarsana News

UT Southwestern Ranked No. 1 in Texas, Fourth in Nation for Tech Transfer

UT Southwestern Medical Center ranked fourth in the nation and No. 1 in Texas for commercializing new biomedical technologies

Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors - Vimarsana News

Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

Investegate announcements from Prothena Corporation plc, Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

Prothena Announces Appointment of Biotechnology Industry - Vimarsana News

Prothena Announces Appointment of Biotechnology Industry

DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust...

The biggest US biotech investments in June 2022 - Vimarsana News

The biggest US biotech investments in June 2022

In addition to recent Independence Day festivities, the U.S. biotech space has other reasons to celebrate. The asthma drug developer Upstream Bio topped the ranks for the U.S.’ biggest early-stage biotech investment in June 2022, but manufacturing heavyweight National Resilience, Inc. bagged the private funding top spot with a huge Series D round.

Bayer, Amgen join $120M financing for startup aiming to expand genetic meds delivery - Vimarsana News

Bayer, Amgen join $120M financing for startup aiming to expand genetic meds delivery

In less than one year, ReCode Therapeutics has reeled in $200 million in financing. Big pharmaceutical companies are taking notice of the biotech startup’s technology, which enables lipid nanoparticles to go a wide range of organs and tissues, potentially broadening the reach of genetic medicines.